Literature DB >> 16306434

Mechanisms of statin-induced myopathy: a role for the ubiquitin-proteasome pathway?

M John Chapman, Alain Carrie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16306434     DOI： 10.1161/10.1161/01.ATV.0000194548.11901.a4

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  10 in total

Review 1.  Understanding patients' perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review.

Authors:  Ying Jie Chee; Hian Hui Vincent Chan; Ngiap Chuan Tan
Journal:  Singapore Med J       Date:  2014-08       Impact factor: 1.858

2.  Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications.

Authors:  Jim S Wu; Catherine Buettner; Howard Smithline; Long H Ngo; Robert L Greenman
Journal:  Muscle Nerve       Date:  2011-01       Impact factor: 3.217

3.  Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.

Authors:  Mark Screen; Per Harald Jonson; Olayinka Raheem; Johanna Palmio; Reijo Laaksonen; Terho Lehtimäki; Mario Sirito; Ralf Krahe; Peter Hackman; Bjarne Udd
Journal:  Am J Pathol       Date:  2014-06-05       Impact factor: 4.307

4.  Rhabdomyolysis in the setting of induced hypothyroidism and statin therapy: a case report.

Authors:  Yaser Jbara; Dean Bricker
Journal:  Eur Thyroid J       Date:  2015-02-18

Review 5.  Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies.

Authors:  Richard Kones; Umme Rumana
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

6.  Curcumin improves atorvastatin-induced myotoxicity in rats: Histopathological and biochemical evidence.

Authors:  Said Said Elshama; Ayman El-Meghawry El-Kenawy; Hosam-Eldin Hussein Osman
Journal:  Int J Immunopathol Pharmacol       Date:  2016-08-09       Impact factor: 3.219

Review 7.  Myopathy with statin-fibrate combination therapy: clinical considerations.

Authors:  Terry A Jacobson
Journal:  Nat Rev Endocrinol       Date:  2009-07-28       Impact factor: 43.330

Review 8.  Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine.

Authors:  Elliott Antman; Scott Weiss; Joseph Loscalzo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-05-11

9.  Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment.

Authors:  Tjeerd P van Staa; Daniel F Carr; Helen O'Meara; Gerry McCann; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

Review 10.  Drug-induced impairment of renal function.

Authors:  George Sunny Pazhayattil; Anushree C Shirali
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-12-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.